Breaks Categories: Stock Spotlights

ThursdayDec 21, 2017 12:56 pm

HempNewsBreaks – Marijuana Company of America, Inc. (MCOA) Poised for Action in Cannabinoid Health Industry

Amid the industry and consumer enthusiasm accompanying the expansion of marijuana product legalization throughout the United States and across the globe, the Marijuana Company of America (OTC: MCOA) is preparing to develop and market hemp-derived nutritional and wellness products. MCOA’s subsidiary hempSMART is committed to producing clinically tried cannabinoid formulations and delivering them through a convenient and discreet network. An article discussing this reads: “hempSMART places a high priority on using the best quality extracts from hemp plants that are produced and processed to maximize cannabinoid concentration and potency. The company currently has two CBD-based products available for distribution. The…

Continue Reading

ThursdayDec 21, 2017 12:47 pm

HempNewsBreaks – Skinvisible, Inc. (SKVI) May Target Booming Pain Management Market Through Proposed Merger with Quoin Pharmaceuticals

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a Letter of Intent (“LOI”) regarding a proposed merger with Quoin Pharmaceuticals Limited. The potential partnership could target significant unmet medical needs on the pain management market. An article discussing this reads: “Currently, the pain management market in the U.S. is fueled by a number of sectors. The most prominent ones include post-operative pain relief, arthritis pain, cancer pain, migraine and neuropathic pain. As larger Western populations age and become susceptible to an array of medical conditions, the need for new pain management developments will grow even larger. The…

Continue Reading

FridayDec 15, 2017 1:07 pm

HempNewsBreaks – Medical Cannabis Payment Solutions (REFG) Offers Cashflow Alternatives for Cannabis Industry

Wyoming’s Medical Cannabis Payment Solutions (OTC: REFG) has established a pioneering method of merchant processing that sustains industry businesses and is compliant with the U.S. federal government’s laws in their current state. REFG’s subsidiary StateSourced provides an alternative payment method for companies unable to work with banks in tracking sales and tax collections for cannabis-related products because of the Controlled Substance Act. An article discussing this reads: “Medical Cannabis Payment Solutions and its StateSourced specialized digital payment platform ensures full compliance with all laws affecting the cannabis industry while delivering full-spectrum merchant processing services (http://cnw.fm/tKb6U). Medical Cannabis Payment Solutions is…

Continue Reading

FridayDec 15, 2017 12:58 pm

HempNewsBreaks – Skinvisible, Inc. (SKVI) Advances Invisicare Delivery System

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) is targeting the pharmaceutical industry with its proprietary drug delivery system, Invisicare. Invisicare improves the delivery of ingredients to and through the skin. An article discussing this reads: “Skinvisible has developed over 40 product formulations using Invisicare both in the medical and skincare markets, in addition to being granted 14 patents. The company is focused on licensing its formulations and Invisicare to other companies in the pharmaceutical and cosmeceutical industries. The company’s business model emphasizes four revenue streams that include fees for new product development, license fees, sales of branded products,…

Continue Reading

TuesdayDec 12, 2017 1:56 pm

HempNewsBreaks – Global Payout, Inc. (GOHE) Directed by Executive Talent and Experience

Global Payout (OTC: GOHE) has distinguished itself as a premier global payment solutions provider lead by a seasoned executive team. An article discussing this reads: “Founder James Hancock, CEO and chairman of the board of Global Payout, has over thirty years’ experience in multiple executive capacities in financial services, investment banking, mergers and acquisitions, telecommunications and payment processing. Prior to founding Global Payout, Hancock, who holds a Juris Doctorate from the California School of Law, specialized in the financial services sector for 14 years and launched nearly 40 custom-designed prepaid debit card programs. Operating as a prepaid card services company,…

Continue Reading

MondayDec 11, 2017 5:16 pm

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Develops Cannabis-Based Therapeutics in Response to Opioid Epidemic

Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is using scientific research and development to stake out its spot in the medical marijuana industry. An article discussing this reads: “Veritas Pharma’s mission is to develop and commercialize the most effective cannabis strains, backed by clinical data. This innovative research and development path aims to solve the critical need for real science to support claims surrounding medical marijuana. The company’s approach, combined with its strategic alliances, will effectively address the medical community’s concerns over the complexities of cannabis potency, efficacy, quality and content in the…

Continue Reading

MondayDec 11, 2017 3:53 pm

HempNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Utilizes Proprietary Advanced Biosynthesis Process to Develop Cannabinoids-based Therapies

InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) remains focused on discovering potential breakthrough cannabinoid-based therapies by utilizing its proprietary cannabinoid biosynthesis process and its bioinformatics drug and disease targeting tool. An article discussing this reads: “Other biopharmaceutical companies may produce cannabinoids in the laboratory using chemical synthesis, but there’s a litany of drug development efforts with synthetic molecules that have failed. The proprietary biosynthesis process used by InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) is unique. Producing cannabinoids that are identical to naturally occurring compounds is transformative for drug development. By using its proprietary process, InMed is able to manufacture exact…

Continue Reading

MondayDec 11, 2017 3:39 pm

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Sets its Sights on Booming Global Cannabis Industry

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) patented delivery technology, DehydraTECH™ has positioned the company at the forefront of the thriving global cannabis industry. A recent article discussing this reads: “LXRP’s technology enables improved delivery of bioactive substances via oral ingestion that results in increased absorption without the need for unhealthy practices of inhalational dosing that result in damaging affects to the lungs. The technology also eliminates the need for co-administration with unhealthy sugars or sweeteners in delivery that are commonly used to mask the bitter tastes. With DehydraTECH™, bioactive substance delivery is improved by combining molecules with certain fatty acids…

Continue Reading

FridayDec 08, 2017 12:42 pm

HempNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) DehydraTech™ Shines in Vegas Lights

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) attracted a lot of attention in Las Vegas at this year’s Marijuana Business Conference & Expo due to increased awareness about potential health benefits of cannabinoids and an increased demand for improved CBD-based edibles. A recent article highlights keen interest in Lexaria’s patented DehydraTECH™ delivery technology, stating, “Lexaria’s proprietary technology has been awarded patents in the U.S. and Australia, and it has patents pending in more than 40 other countries. Furthermore, it is the only company in the world to date that has a patent allowed for the oral delivery of all non-psychoactive cannabinoids,…

Continue Reading

FridayDec 08, 2017 12:41 pm

HempNewsBreaks – Skinvisible, Inc. (SKVI) Poised for Growth More than Skin Deep

Skinvisible (OTCQB: SKVI) is poised for growth in the booming global topical drug delivery market. A recent article highlights the company’s positioning, stating, “The Nevada-based Company, which develops topical, transdermal and mucosal polymer-based drug delivery systems and formulations that incorporates its patent-pending technology for combining hydrophilic and hydrophobic polymer, is a player in an industry poised to double in size over the next seven years. A new market research report estimates the global topical drug delivery market will grow at a CAGR of 9.2% from USD 101.7 billion in 2016 to reach USD 205.1 billion by 2024. This is good…

Continue Reading